A med tech case decided by the PTAB is helpful to inform patent strategy for AI enabled inventions across various disciplines and industries. Patent applicants should expect to see reliance by the ...

About 15 years ago, the St. Louis-based Monsanto corporation developed “Roundup Ready,” genetically modified soybean seeds that are resistant to herbicides also produced by the company. In other words ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

The US Court of Appeals for the Federal Circuit concluded that claims directed to “pharmaceutical batches” must be produced in accordance with a particular patent example, upholding a finding of ...

On January 7, 2019, the U.S. Patent and Trademark Office published updated examination guidance, instructing the examining corps and the PTAB how they should apply 35 U.S.C. § 101. On the same day, ...

“Unfortunately, not nearly enough individuals and companies are seeking design patent protection. In 2019, for example, there were 46,847 design patent applications filed, which represents 7.01% of ...

On May 6, 2016, the U.S. Patent and Trademark Office released new life science examples on subject matter eligibility (Examples 28-32, consecutively numbered after the previously released USPTO ...

The Recentive decision exemplifies the Federal Circuit’s skepticism toward claims that dress up longstanding business problems in machine-learning garb, while the USPTO’s examples confirm that ...

I've routinely used ZDNet as a bully pulpit directed at both the sellers and buyers of technologies who look to establish or adopt certain standards that have patents connected to them. When a ...

Early this spring, in Hoffmann-La Roche, Inc. v. Promega, the United States Court of Appeals for the Federal Circuit reviewed a district court opinion on the validity of an issued patent 1. The court ...